P

Pfizer

Pfizer has agreed to a $44 million class action settlement to resolve claims that its Chantix smoking cessation drug was contaminated with a nitrosamine.

ClosedUnited States-wideClaim status: Closed on September 14, 2026Payout: VariesNo longer claimable

About this settlement

Allegations that Chantix was contaminated with nitrosamines, a potential carcinogen.

This settlement resolves claims that Pfizer's Chantix smoking cessation drug was contaminated with nitrosamines, a substance that can cause cancer. Consumers and third-party payors who purchased Chantix in the United States between September 29, 2015, and September 17, 2021, may be eligible for compensation.

Who qualifies

  • Consumers and third-party payors who paid for retail purchases of Chantix in the United States.
  • Purchases made between September 29, 2015, and September 17, 2021.

Varies

Claim status: Closed on September 14, 2026

See active Settlements

Related settlements

Estée Lauder logo

Estée Lauder

No proof required

Up to $5,000

Claims opening soon

Silk and Great Value logo

Silk and Great Value

Proof required

Up to $300,000

27 days left

Audible logo

Audible

No proof required

Compensation pending

Claims opening soon

Government of Canada logo

Government of Canada

Proof required

Up to $200,000

677 days left

Meta (Facebook) logo

Meta (Facebook)

No proof required

Up to $90

Claims opening soon

Ticketmaster logo

Ticketmaster

No proof required

Compensation pending

Claims opening soon